Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Emerging Diseases: Disruptive, Commercially Risky, But GSK Has A Solution

Jul 19 2016

• By Donna Young

Zika

Related Content

Fauci: Borrowed Cash Won't Carry Zika Efficacy Trials

Jul 03 2016

GSK/NIH 'SAM' Strategy May Reap Benefits Beyond Zika

Jul 07 2016

GSK to set up global vaccine center near FDA, NIH

Apr 03 2015

Bill Gates: Infectious disease must be attacked like war

Mar 19 2015

Related Companies

GSK plc

Additional Topics

United States Companies Research & Development Clinical Trials Commercial Policy Infectious Diseases BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window